Mylan ups Perrigo bid again and gets rejected

Generic drug maker Mylan ups the ante for Perrigo, and is rejected again.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.